Bruker announces an order valued at over $7.5 million from the University of Minnesota for its new Nuclear Magnetic Resonance (NMR) laboratory, including ultra-high field Avance™ III 900 and Avance™ III 850 NMR spectrometers. The systems will be installed in the newly constructed and greatly expanded NMR Facility at the University of Minnesota.
“Specifically, these new Bruker instruments will enhance this University's position as a world leader in the advancement of biomedical research using magnetic resonance.”
This purchase will form the core of the systems in the NMR Facility for use in a wide range of research at the University of Minnesota, including structure determination of proteins and nucleic acids related to cancer, heart failure, infectious disease, muscular dystrophy, aging, neurodegeneration, and metabolomics.
The Avance™ III 900 system is based on Bruker's successful 900 MHz (21.2 Tesla) actively-shielded US2 magnet, one of the highest magnetic fields for NMR applications. The 900 MHz US2 magnet combines Bruker's proven proprietary UltraShield™ active-shielding and UltraStabilized™ sub-cooling technologies. The result is the most reliable 900 MHz magnet for NMR applications. The Avance™ III 850 spectrometer is based on Bruker's new 850 MHz Ascend™ magnet that combines the key advantages of Bruker's well-established UltraShield™ Plus magnets with advanced superconductor technology resulting in significant reductions in magnetic stray fields and in the size of the cryostat. With over 170 ultra-high field installations worldwide, Bruker has an unmatched track record in NMR magnet technology.
"This purchase demonstrates the University of Minnesota's commitment to excellence in research," said Prof. David Thomas, NMR Facility Director. "Specifically, these new Bruker instruments will enhance this University's position as a world leader in the advancement of biomedical research using magnetic resonance."
Expanding research and clinical options for children with cancer